Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome

<b>Introduction</b>: Treatment with betablockers is controversial in Takotsubo syndrome (TTS); however, many physicians intuitively initiate or continue betablocker therapy in these patients. The effect of preadmission betablocker use on adverse cardiovascular events has not been studied...

Full description

Bibliographic Details
Main Authors: Albert Topf, Moritz Mirna, Christiane Dienhart, Peter Jirak, Nina Bacher, Elke Boxhammer, Sarah X. Gharibeh, Lukas J. Motloch, Uta C. Hoppe, Michael Lichtenauer
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Biomedicines
Subjects:
Takotsubo syndrome
betablocker
adverse cardiovascular events
Online Access:https://www.mdpi.com/2227-9059/10/2/464

Internet

https://www.mdpi.com/2227-9059/10/2/464

Similar Items